Skip to main content

Advertisement

SpringerLink
Log in

BUILDING A BUSINESS

Stepping to the exit

  • Building a Business
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

An Author Correction to this article was published on 05 November 2021

This article has been updated

A historical analysis of oncology deals can help bioentrepreneurs navigate the right time for partnerships and exits and can inform on the type of investors likely to be interested.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1: Deal stage of oncology venture at time of acquisition.
Fig. 2: Capital invested in oncology ventures until exit.
Fig. 3: Number of oncology venture financings and type of investors.
Fig. 4: Roadmap to exit.

Change history

References

  1. Prencipe, D. The European venture capital landscape: an EIF perspective. Volume III: Liquidity events and returns of EIF-backed VC investments. https://www.fi-compass.eu/sites/default/files/publications/eif_wp_41.pdf(European Investment Fund, 2017).

  2. Booth, B. New data on venture capital returns: exits are indeed improving. Forbes https://www.forbes.com/sites/brucebooth/2012/10/03/new-data-on-venture-capital-returns-exits-are-indeed-improving/?sh=36f724379d69 (2012).

  3. Thomas, D. et al. Clinical development success rates and contributing factors 2011–2020. https://www.bio.org/clinical-development-success-rates-and-contributing-factors-2011-2020 (BIO | QLS Advisors | Informa UK, 2021).

  4. Paul, S. M. et al. Nat. Rev. Drug Discov. 9, 203–214 (2010).

    Article  CAS  Google Scholar 

  5. Micklus, A. & Giglio, P. Nat. Rev. Drug Discov. 19, 87–88 (2020).

    Article  CAS  Google Scholar 

  6. Giniatullina, A., Boorsma, M., Mulder, G. J. & van Deventer, S. Nat. Biotechnol. 31, 284–287 (2013).

    Article  CAS  Google Scholar 

  7. Melchner von Dydiowa, G., van Deventer, S. & Couto, D. S. Nat. Biotechnol. 39, 266–269 (2021).

    Article  CAS  Google Scholar 

  8. Hardison, S. Biopharma Dealmakers 15, 83–85 (2021).

    Google Scholar 

  9. Albrecht, B., Capra, E., Reichert, M. & Salazar, P. Precision medicine in practice: strategies for rare cancers. https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/precision-medicine-in-practice-strategies-for-rare-cancers (McKinsey, 2021).

  10. Fidler, B. Record numbers of biotechs are going public. Here’s how they’re performing. BioPharma Dive https://www.biopharmadive.com/news/biotech-ipo-performance-tracker/587604/ (2021).

  11. Cameron, T. & Morrison, C. Nat. Rev. Drug Discov. 20, 93–94 (2021).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Aglaia Oncology Funds, Bilthoven, the Netherlands

    Christiaan M. de Bloeme, Robin W. Jansen, Mark R. L. Krul & Ernst-Jan Geutjes

Authors
  1. Christiaan M. de Bloeme
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robin W. Jansen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mark R. L. Krul
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ernst-Jan Geutjes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ernst-Jan Geutjes.

Ethics declarations

Competing interests

All authors are employed by Aglaia Oncology Funds, which invests in oncology start-ups.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Bloeme, C.M., Jansen, R.W., Krul, M.R.L. et al. Stepping to the exit. Nat Biotechnol 39, 1048–1054 (2021). https://doi.org/10.1038/s41587-021-01007-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41587-021-01007-1

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation